1. Home
  2. UFG vs HBIO Comparison

UFG vs HBIO Comparison

Compare UFG & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Uni-Fuels Holdings Limited

UFG

Uni-Fuels Holdings Limited

HOLD

Current Price

$0.72

Market Cap

27.6M

Sector

Energy

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$6.00

Market Cap

26.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFG
HBIO
Founded
2021
1901
Country
Singapore
United States
Employees
26
N/A
Industry
Oil Refining/Marketing
Biotechnology: Laboratory Analytical Instruments
Sector
Energy
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
27.6M
26.5M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
UFG
HBIO
Price
$0.72
$6.00
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.00
AVG Volume (30 Days)
98.4K
12.7K
Earning Date
04-22-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$116,176,000.00
Revenue This Year
$3.95
$4.77
Revenue Next Year
N/A
$8.55
P/E Ratio
$211.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.38
52 Week High
$9.91
$7.50

Technical Indicators

Market Signals
Indicator
UFG
HBIO
Relative Strength Index (RSI) 49.45 47.55
Support Level $0.64 $5.91
Resistance Level $0.88 $6.70
Average True Range (ATR) 0.07 0.28
MACD -0.00 -0.04
Stochastic Oscillator 49.02 12.20

Price Performance

Historical Comparison
UFG
HBIO

About UFG Uni-Fuels Holdings Limited

Uni-Fuels Holdings Ltd is a service provider of marine fuel solutions. It operates on an integrated business model, serving customers through two operating models: sales of marine fuels solutions and brokerage (i.e., acting as an intermediary between marine fuels suppliers and customers for a commission). The various marine fuel products offered by the company include very low sulfur fuel oil, high sulfur fuel oil, marine gas oil, and bio marine fuel. Its customers are mainly shipping companies and other fuel suppliers operating in market sectors such as bulk, tanker, offshore, container, general cargo, tug and barge, car carrier, cruise, yacht, and dredging. Geographically, the company derives maximum revenue from Singapore, and the rest from Malaysia, Hong Kong, China, and other regions.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: